Bhrer C, Endesfelder S, Scheuer T, Schmitz T
Drug Resist Update
45 Identifying Optimal Candidates for GLP-1RA Therapy in Heart Failure The selection of patients with HF for GLP-1RA therapy requires careful consideration of the HF phenotype, comorbidities and available evidence
This process succeeds in approximately 70% of cases with proper medical justification
Is synovial macrophage activation the inflammatory link between obesity and osteoarthritis
K23 DK116720-01), in addition to research support by Juvenile Diabetes Research Foundation (JDRF), NIDDK/DiaComp, NIDDK/KPMP, Thrasher Research Fund, International Society of Pediatric and Adolescent Diabetes (ISPAD), Colorado Clinical & Translational Sciences Institute (CCTSI) and Center for Womens Health Research at University of Colorado